Analyst Recommendations

UBS analyst issues NEUTRAL recommendation for BKR on October 6, 2025 09:39AM ET. The previous analyst recommendation was Neutral.BKR was trading at $48.5 at issue of the analyst...

October 6, 2025   BKR -0.54%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MPC on October 3, 2025 11:31AM ET. The previous analyst recommendation was Overweight.MPC was trading at $192.24 at issue of the...

October 3, 2025   MPC 1.06%

HSBC analyst issues BUY recommendation for OXY on October 3, 2025 09:04AM ET. The previous analyst recommendation was Hold.OXY was trading at $44.23 at issue of the analyst...

October 3, 2025   OXY 1.93%

Roth Capital analyst issues NEUTRAL recommendation for OXY on October 2, 2025 12:38PM ET. The previous analyst recommendation was Neutral.OXY was trading at $45.745 at issue of the...

October 2, 2025   OXY 1.93%

Morgan Stanley analyst issues OVERWEIGHT recommendation for WMB on October 2, 2025 12:19PM ET. The previous analyst recommendation was Overweight.WMB was trading at $64.84 at issue of the...

October 2, 2025   WMB 1.38%

Barclays analyst issues OVERWEIGHT recommendation for SHLS on October 2, 2025 10:07AM ET. The previous analyst recommendation was Equal-Weight.SHLS was trading at $7.93 at issue of the analyst...

October 2, 2025   SHLS 5.46%

Jefferies analyst issues BUY recommendation for FSLR on October 2, 2025 10:49AM ET. The previous analyst recommendation was Buy.FSLR was trading at $224.82 at issue of the analyst...

October 2, 2025   FSLR -1.42%

UBS analyst issues BUY recommendation for SHLS on October 1, 2025 11:08AM ET. The previous analyst recommendation was Buy.SHLS was trading at $7.41 at issue of the analyst...

October 1, 2025   SHLS 5.46%

Jefferies analyst issues BUY recommendation for RUN on October 1, 2025 09:49AM ET. The previous analyst recommendation was Hold.RUN was trading at $17.29 at issue of the analyst...

October 1, 2025   RUN 2.71%

TD Securities analyst issues BUY recommendation for CVE on September 30, 2025 02:19PM ET. The previous analyst recommendation was Buy.CVE was trading at $16.99 at issue of the...

September 30, 2025   CVE -0.74%